#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cytomegalovirus infection Cerebral haemorrhage Acute myeloid leukaemia refractory Fatty acid oxidation disorder Short-bowel syndrome Ehlers-Danlos syndrome Demyelination Palmar-plantar erythrodysaesthesia syndrome Hyperoxaluria Prolymphocytic leukaemia Retinoblastoma Prophylaxis against transplant rejection Von Hippel-Lindau disease Prader-Willi syndrome Polycystic liver disease More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent Short-bowel syndrome – Trials in Disease Mucopolysaccharidosis II – Treatment Alexander disease – Trials in Disease Synovial sarcoma metastatic – Trials in Disease KBG syndrome – Diagnostics Synovial sarcoma – Life with Disease Synovial sarcoma – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Osteosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Op-1250 Degarelix Pariglasgene Brecaparvovec Trifluridine Levobupivacaine Nirmatrelvir Lactose ZINC Hydroxi-Methionine Calcium Bisacodyl Isoprenaline Hydrochloride Pembrolizumab Paclitaxel Albumin-Bound Dirocaftor Cobamamide H2-Receptor Antagonist Bgb-15025 Citrate Tamoxifen Citrate Pbf-999 Regadenoson More therapies…

    Learn about Your Condition

    Neoplasm Chondrosarcoma metastatic Endocarditis Hairy cell leukaemia Bladder cancer stage III Myeloid leukaemia Endocarditis bacterial Myocardial ischaemia Gastrooesophageal cancer Neonatal anoxia Cough Mumps Colorectal cancer stage III Cutibacterium acnes infection Neurodermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of High-Dose Hydroxocobalamin for Patients with Cobalamin Deficiency

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • COBALAMIN
    Spain

  • Study on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Mitotane
    • Cemiplimab
    Italy

  • Study on the Effects of D-Cycloserine and Brain Stimulation for Patients with Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    The Netherlands

  • Study on the Effects of Mitapivat on Brain Blood Flow and Oxygen Use in Patients with Sickle Cell Anemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Mitapivat
    The Netherlands

  • Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    The Netherlands

  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    • Thymic carcinoma
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Fluorouracil
    France
Previous Page
1 … 792 793 794 795 796 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!